Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Kim Linton

Name: The encouraging early results of NX-5948, a novel BTK degrader, in patients with R/R CLL and NHL
Uploaded: 2024-06-16T00:00:00Z
Duration: 4 min 42 s

MBChB, MRCP, PhD, FRCP

University of Manchester

Sorry, no posts matched your criteria.

Kim Linton

Cookie settings